Lithium therapy and delayed progression of Alzheimer's disease and related dementias in patients with bipolar disorder and mild neurocognitive disorders
Weckstein, A. R.; Carr, S.; Wang, P.; Krüger, N.; Danaei, G.; Schneeweiss, S.; Desai, R. J.
Show abstract
Recent mechanistic evidence identifies lithium deficiency as a driver of Alzheimers disease and related dementias (ADRD) pathogenesis. To evaluate this hypothesis in a population-based setting, we emulated a target trial comparing ADRD progression after initiation of lithium versus antiepileptic mood stabilizers among adults [≥]55 years with bipolar disorder and mild neurocognitive disorder, using US Medicare claims with replication in two commercial databases. Lithium initiation was associated with a lower 5-year risk of progression to advanced ADRD (risk ratio 0.87; 95% CI 0.78-0.99) and long-term care stay with ADRD (0.75; 0.56-0.97). Lower risks were most pronounced in patients with later stages of mild cognitive impairment. Results were consistent across sensitivity analyses and replications. Validations using linked cognitive assessments from standardized instruments strengthened confidence in findings. While results may be susceptible to residual bias, this study supports investigating lithiums potential to delay ADRD progression with randomized trials of optimized lithium formulations.
Matching journals
The top 10 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Disease progression modelling reveals heterogeneity in trajectories of Lewy-type alpha-synuclein pathology 92%
- Deep clinical phenotyping of Alzheimer’s Disease Patients Leveraging Electronic Medical Records Data Identifies Sex-Specific Clinical Associations 91%
- Cell-type-specific Alzheimer’s disease polygenic risk scores are associated with distinct disease processes in Alzheimer’s disease 91%
Similar papers in this journal
- Genetic analysis of retinal cell types reveals synaptic pathology in schizophrenia 89%
- Longitudinal Changes in Functional Connectivity in Antipsychotic-treated and Antipsychotic-naive Patients with First Episode Psychosis 89%
- A Survey of Copy Number Variants Associated with Neurodevelopmental Disorders in a Large-Scale, Multi-Ancestry Biobank 88%
Similar papers in this journal
Similar papers in this journal
- Exploring the Feasibility of Using Real-World Data from a Large Clinical Data Research Network to Simulate Clinical Trials of Alzheimer’s Disease 92%
- Novel clinical subphenotypes in COVID-19: derivation, validation, prediction, temporal patterns, and interaction with social determinants of health 91%
- Federated Target Trial Emulation using Distributed Observational Data for Treatment Effect Estimation 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.